Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2018 1
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: molina e. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Efficacy was assessed using logistic regression and validated using inverse probability of treatment weighting propensity score. The median time to biochemical response (BR) was 3.1 months in patients treated with budesonide and 4.9 months in those with prednisone. …
Efficacy was assessed using logistic regression and validated using inverse probability of treatment weighting propensity score. The median …
Nutritional aspects in chronic non-cancer pain: A systematic review.
Xu Lou I, Gil-García E, Cáceres-Matos R, Ali K, Molina E. Xu Lou I, et al. Among authors: molina e. Front Nutr. 2022 Aug 8;9:931090. doi: 10.3389/fnut.2022.931090. eCollection 2022. Front Nutr. 2022. PMID: 36003834 Free PMC article.
OBJECTIVES: Chronic pain (CP) is an unpleasant emotional and sensory experience that can be accompanied by tissue damage that persists for more than 3 months. Recent studies show that certain nutritional strategies can help to improve pain, so this study is aimed to system …
OBJECTIVES: Chronic pain (CP) is an unpleasant emotional and sensory experience that can be accompanied by tissue damage that persists for m …
A Cross-Sectional Study on the Prevalence and Risk Correlates of Mental Disorders: The GRANADΣP Study.
Cervilla JA, Gutiérrez B, Rodríguez-Barranco M, Ibanez-Casas I, Pérez-García M, Valmisa E, Carmona J, Molina E, Moreno-Kustner B, Rivera M, Lozano V, Muñoz-Negro JE, Ching A, Guerrero M, Porras-Segovia A, Ruiz-Pérez I. Cervilla JA, et al. Among authors: molina e. J Nerv Ment Dis. 2018 Sep;206(9):716-725. doi: 10.1097/NMD.0000000000000873. J Nerv Ment Dis. 2018. PMID: 30124573
A final sample of 809 participants (response rate, 69.3%) were screened for mental disorder (MD) using the MINI International Neuropsychiatric Interview, a comprehensive interview validated to generate diagnoses compatible with ICD-10/DSM-4 criteria. Current (1-month) prev …
A final sample of 809 participants (response rate, 69.3%) were screened for mental disorder (MD) using the MINI International Neuropsychiatr …
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
Gomez E, Garcia Buey L, Molina E, Casado M, Conde I, Berenguer M, Jorquera F, Simón MA, Olveira A, Hernández-Guerra M, Mesquita M, Presa J, Costa-Moreira P, Macedo G, Arenas JI, Manuel Sousa J, Ampuero J, Morillas RM, Santos A, De Carvalho A, Uriz J, Carrión JA, Luisa Gutiérrez M, Pérez-Fernández E, Fernández-Rodríguez CM; IBER-PBC leading Cooperative Group. Gomez E, et al. Among authors: molina e. Aliment Pharmacol Ther. 2021 Feb;53(4):519-530. doi: 10.1111/apt.16181. Epub 2020 Dec 12. Aliment Pharmacol Ther. 2021. PMID: 33314220
Effectiveness was assessed by the changes in GLOBE and UK-PBC scores from baseline. POISE and Paris II criteria were evaluated after 12 months of OCA . Liver fibrosis was evaluated by FIB-4 and AST to platelet ratio index (APRI). ...
Effectiveness was assessed by the changes in GLOBE and UK-PBC scores from baseline. POISE and Paris II criteria were evaluated after 12 m …
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients.
Suárez E, Buti M, Rodríguez M, Prieto M, Pascasio-Acevedo JM, Casanovas T, Crespo J, Tapiador JAR, Gómez-Rodríguez R, Figueruela B, Diago M, Morillas RM, Zozaya JM, Calleja JL, Casado M, Molina E, Fuentes J, Simón MA. Suárez E, et al. Among authors: molina e. Eur J Gastroenterol Hepatol. 2019 Feb;31(2):267-271. doi: 10.1097/MEG.0000000000001289. Eur J Gastroenterol Hepatol. 2019. PMID: 30576297
A total of 69 patients with hepatitis-B-e antigen-positive or hepatitis-B-e antigen-negative CHB with undetectable HBsAg during NA treatment were included after discontinuation of treatment, and followed up for a median period of 37.8 months (interquartile range: 23.8-54.6 …
A total of 69 patients with hepatitis-B-e antigen-positive or hepatitis-B-e antigen-negative CHB with undetectable HBsAg during NA treatment …
Variability in the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption.
Gutiérrez B, Rivera M, Obel L, McKenney K, Martínez-Leal R, Molina E, Dolz M, Ochoa S, Usall J, Haro JM, Ruiz-Veguilla M, Torres F, Cervilla J. Gutiérrez B, et al. Among authors: molina e. Rev Psiquiatr Salud Ment. 2009 Apr;2(2):89-94. doi: 10.1016/S1888-9891(09)72250-5. Epub 2009 Sep 25. Rev Psiquiatr Salud Ment. 2009. PMID: 23034243 English, Spanish.
Cannabis use was measured by taking into account the frequency of intake during the previous month. Logistic regression models were used to test the interaction between genetic and environment factors. ...
Cannabis use was measured by taking into account the frequency of intake during the previous month. Logistic regression models were u …
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E. Castroagudín JF, et al. Among authors: molina e. Liver Transpl. 2009 Dec;15(12):1792-7. doi: 10.1002/lt.21920. Liver Transpl. 2009. PMID: 19938140 Free article. Clinical Trial.
Periodic controls of the weight, arterial pressure, liver function tests, serum creatinine, everolimus levels, proteinuria, creatinine clearance, and glomerular filtration rate at days 30, 90, 180, and 360 were made. After a median follow-up of 19.8 months, the respective …
Periodic controls of the weight, arterial pressure, liver function tests, serum creatinine, everolimus levels, proteinuria, creatinine clear …